Search
Menu
Home
HTB
2018
July
HTB
July 2018
Contents
Editorial
11 July 2018: vol 19 no 12: DTG and preconception – special report
Special reports
Fit for purpose: Antiretroviral treatment optimisation July 2018
Fit for purpose 2018 – PDF
HIV pipeline 2018: full version
Dolutegravir preconception signal: time is up for shoddy surveillance
Conference reports
What to watch: HIV cure-related research at AIDS 2018
AIDS 2018: Programme online and late-breaker highlights announced three weeks before the conference
Antiretrovirals
Bictegravir/FTC/TAF (Biktarvy) approved in Europe
Women's health
Dolutegravir: need to consider all pros and cons before switching in pregnancy
Pregnancy
Why U=U does not apply to breastfeeding
PDFs
11 July 2018: vol 19 no 12
HTB RSS
Early access
Zero transmission in France for mothers on ART from conception with undetectable viral load at delivery
30 January 2023
56 Dean Street as a nurse-led PrEP clinic: >20,000 clients in 2021
27 January 2023
Phase 3 Mosaico HIV vaccine efficacy trial stopped early due to lack of benefit
27 January 2023
All early access reports
Current issues
January 2023
December 2022
October 2022
Back issues
Special report
Latest statistics on HIV in the UK: data for 2021
1 December 2022
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage